Drug intelligence / Profile preview

Biotex

Development stage: Unknown
Lead developer: Purgo Biologics
Administration: Local Surgical Use

Overview

Biotex is a non-resorbable, monofilament surgical suture developed by Purgo Biologics specifically for oral and dental surgical applications. Composed of 100% polytetrafluoroethylene (PTFE), the suture is sterile, uncoated, and undyed, featuring a stainless-steel surgical needle. It is indicated for soft tissue approximation and wound closure in various procedures, including bone grafting, periodontal surgery, guided tissue regeneration (GTR), ridge augmentation, and dental implant surgery. The PTFE material is biologically inert and provides a smooth surface that helps prevent bacterial adhesion and plaque formation, thereby reducing the risk of infection and promoting optimal wound healing in the oral cavity.

Brand names: Biotex
Other names: PTFE suture

Beyond the preview

Go deeper on Biotex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotex.

Explore the full profile